Claris Lifesciences Ltd. IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 7,579,487 (60%) | — | ₹17,812 Cr |
| NII (HNI) | — | 1,263,247 (10%) | — | ₹2,969 Cr |
| Retail | — | 3,789,743 (30%) | — | ₹8,906 Cr |
| Σ Total | — | 12,632,477 (100%) | — | ₹296,863 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 22 | ₹5,170 |
| Retail (Max) | 13 | 286 | ₹67,210 |
| S-HNI (Min) | 14 | 308 | ₹72,380 |
| B-HNI (Min) | 67 | 1,474 | ₹346,390 |
Financial Statements Amount in ₹ Crore
| Metric | 31-Dec-09 | 31-Dec-08 | 31-Dec-07 |
|---|---|---|---|
| Revenue | 759 | 764 | 624 |
| Profit After Tax | 130 | 108 | 83 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- 1 Setting up of a new plant comprising a small volume parenterals line, a PVC bag line, a non-PVC bag line and a fat emulsion line. – 131.59
- 2 Setting up of a new manufacturing line for propofol and other fat emulsion products at the existing plant, Clarion IV. – 26.47
- 3 Construction of a facility for research and development at the Clarion manufacturing facilities. – 38.41
- 4 Prepayment of an identified term loan. – 45.91
- 5 General corporate purposes. – 31.89
Company Overview
Incorporated in 1994, Claris Lifesciences Limited (CLL) is an Ahmedabad based pharmaceutical company. Claris is the largest Indian sterile injectables pharmaceutical companies with a presence in 76 countries worldwide. Claris offers 113 products across multiple markets and therapeutic areas. All of these products are off-patent products.
Claris's product range across various therapeutic segments, including anaesthesia, critical care, anti-infectives, renal care, infusion therapy, enteral nutrition, parenteral nutrition and oncology.
Companies more than half of the sales come from international markets and have a strong presence in regions of Latin America, the Middle East, Africa and Central, South East and Far East Asia.
Claris's manufacturing facilities are located in Ahmedabad, India and approved by foreign regulatory authorities. The manufacturing facilities are ISO 9001-2000 and WHO GMP certified.